# OnCo record vt3989 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/vt3989/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "vt3989" ;
  schema:name "VT3989"@en ;
  schema:description "VT3989 is an experimental pill from Vivace Therapeutics, in phase 2 trials for mesothelioma."@en ;
  schema:url <https://onco.cc/drugs/vt3989/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.biospace.com/press-releases/vivace-therapeutics-raises-35-million-in-series-d-financing-to-support-clinical-development-of-first-in-class-cancer-drug-targeting-the-hippo-pathway>, <https://clinicaltrials.gov/study/NCT04665206>, <https://clinicaltrials.gov/study/NCT07824986> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Small molecule, oral" ;
  onco:cancers <https://onco.cc/cancers/mesothelioma/>, <https://onco.cc/cancers/pleural-mesothelioma/> ;
  onco:companies <https://onco.cc/companies/vivace-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct04665206/>, <https://onco.cc/trials/nct07824986/> .